₹841.85
▼ -3.55 -0.42%
29 Jul 2026
NSE Listed · Pharmaceuticals
Granules India Limited (GRANULES)
Volume: 4,06,648Avg Vol 1W: 7,07,778Avg Vol 1M: 12,59,05652W Range:₹432.6₹910
Key Ratios
Checked 7h agoMarket Cap₹21,312 Cr
Current Price₹841.85
Previous Close₹845.4
High / Low (52w)₹910 / ₹432.6
Volume4,06,648
Avg Vol (1W)7,07,778
Avg Vol (1M)12,59,056
Stock P/E104.5
Book Value₹205.21
Dividend Yield0.23%
ROE11.7%
ROA7.71%
Revenue (TTM)—
Revenue Growth-0.55%
Profit Margin11.15%
Total Debt₹312 Cr
Shares Outstanding25 Cr
Face Value₹1
EPS (TTM)₹8.23
P/B4.19
Debt / Equity0.3
50 DMA₹810.68
200 DMA₹652.89
Day change-0.42%
Price Chart
₹841.85▲ 71.65% · 1Y
2025-07-292026-07-29
20-day avg volume: 12.5L shares
Pros
- Company is almost debt-free.
Cons
- Stock trades at a high P/E of 105.
Quarterly Results
| Metric | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹967 Cr | ₹1,138 Cr | ₹1,197 Cr | ₹1,210 Cr | ₹1,297 Cr | ₹1,388 Cr | ₹1,471 Cr | ₹1,477 Cr |
| EBITDA | ₹154 Cr | ₹179 Cr | ₹191 Cr | ₹194 Cr | ₹205 Cr | ₹231 Cr | ₹279 Cr | ₹262 Cr |
| Net Profit | ₹97 Cr | ₹118 Cr | ₹152 Cr | ₹113 Cr | ₹131 Cr | ₹150 Cr | ₹202 Cr | ₹180 Cr |
| EPS | — | — | — | — | — | — | — | — |
Profit & Loss (Annual)
| Metric | Mar 2025 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹4,495 Cr | ₹768 Cr | ₹810 Cr | ₹892 Cr | ₹895 Cr | ₹877 Cr | ₹5,386 Cr | ₹802 Cr |
| EBITDA | ₹733 Cr | ₹109 Cr | ₹117 Cr | ₹179 Cr | ₹166 Cr | ₹148 Cr | ₹909 Cr | ₹106 Cr |
| Net Profit | ₹502 Cr | ₹94 Cr | ₹69 Cr | ₹121 Cr | ₹112 Cr | ₹99 Cr | ₹595 Cr | ₹72 Cr |
| EPS | 20.68 | — | — | — | — | — | 24.46 | — |
Balance Sheet
| Metric | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | ₹2,983 Cr | ₹3,228 Cr | ₹3,713 Cr | ₹4,513 Cr | ₹4,905 Cr | ₹5,521 Cr | ₹6,253 Cr | ₹7,720 Cr |
| Total Liabilities | ₹1,453 Cr | ₹1,385 Cr | ₹1,540 Cr | ₹1,926 Cr | ₹2,070 Cr | ₹2,295 Cr | ₹2,537 Cr | ₹2,635 Cr |
| Equity | ₹1,529 Cr | ₹1,844 Cr | ₹2,173 Cr | ₹2,587 Cr | ₹2,835 Cr | ₹3,226 Cr | ₹3,716 Cr | ₹5,085 Cr |
| Total Debt | — | — | — | — | — | — | — | — |
Cash Flow
| Metric | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Operating | ₹351 Cr | ₹595 Cr | ₹624 Cr | ₹477 Cr | ₹915 Cr | ₹630 Cr | ₹1,010 Cr | ₹1,033 Cr |
| Investing | ₹-270 Cr | ₹-161 Cr | ₹-277 Cr | ₹-380 Cr | ₹-191 Cr | ₹-360 Cr | ₹-691 Cr | ₹-773 Cr |
| Financing | ₹-17 Cr | ₹-213 Cr | ₹-299 Cr | ₹190 Cr | ₹-440 Cr | ₹8 Cr | ₹-93 Cr | ₹379 Cr |
| Free Cash Flow | ₹351 Cr | ₹595 Cr | ₹624 Cr | ₹477 Cr | ₹915 Cr | ₹630 Cr | ₹1,010 Cr | ₹1,033 Cr |
Shareholding
Promoter 38.02% Institutions 33.61% Public 28.38%
Efficiency & Working Capital
ROCE15.6%
Interest Coverage7.9
Dividend Payout—
Debtor Days62 d
Inventory Days114 d
Payable Days46 d
Cash Conversion Cycle130 d
Working Capital Days176 d
Shareholding Details
As of 2026-06-30
Promoter38%
FII17.5%
DII16.1%
Institutions33.6%
Public28.4%
Promoter Pledge0%
No. of Shareholders1,69,422
Shareholding Pattern
Quarterly — figures in %. Latest 12 quarters.
| Period | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Feb 2026 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 42% | 42% | 38.9% | 38.9% | 38.8% | 38.8% | 38.8% | 38.8% | 38.8% | 38% | 38% | 38% |
| FIIs | 18.8% | 19.6% | 20.4% | 19.5% | 15.9% | 15.1% | 13.2% | 14.1% | 13.5% | 13.8% | 15.3% | 17.5% |
| DIIs | 10.1% | 10.7% | 14.1% | 14.9% | 19.6% | 22.4% | 22.7% | 17.9% | 17.5% | 18.5% | 17% | 16.1% |
| Public | 29.1% | 27.8% | 26.6% | 26.8% | 25.7% | 23.6% | 25.2% | 29.2% | 30.2% | 29.7% | 29.7% | 28.4% |
| Promoter Pledge | 4% | 4% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| No. of Shareholders | 1,90,691 | 1,82,142 | 1,79,870 | 2,02,198 | 1,77,554 | 1,69,802 | 1,69,700 | 1,65,542 | 1,63,184 | 1,63,818 | 1,60,286 | 1,69,422 |
Returns History (ROE / ROCE / ROA)
| Period | ROE | ROCE | ROA | P/E |
|---|---|---|---|---|
| 202603 | — | — | — | — |
Major Shareholders (>1%)
| Name | Category | Stake | Shares |
|---|---|---|---|
| Krishna Prasad Chigurupati | Shareholding of Promoter and Promoter Group | 31% | 7.68 Cr |
| Life Insurance Corporation Of India | Public Shareholding | 4.1% | 1.02 Cr |
| Chigurupati Uma Devi | Shareholding of Promoter and Promoter Group | 3.7% | 92,40,761 |
| Sbi Life Insurance Co. Ltd | Public Shareholding | 2.8% | 70,33,983 |
| Kotak Mahindra Life Insurance Company Ltd. | Public Shareholding | 1.7% | 42,12,732 |
| Smallcap World Fund, Inc | Public Shareholding | 1.6% | 39,48,215 |
| Tyche Investments Private Limited | Shareholding of Promoter and Promoter Group | 1.4% | 35,52,557 |
| Aditya Birla Sun Life Trustee Private Limited A/c | Public Shareholding | 1.4% | 35,46,854 |
| Basava Sankara Rao Kolli | Public Shareholding | 1.2% | 29,07,330 |
| 360 One Pipe Fund | Public Shareholding | 1.1% | 27,35,044 |
| Pragnya Chigurupati | Shareholding of Promoter and Promoter Group | 0.7% | 18,42,035 |
| Chigurupati Priyanka | Shareholding of Promoter and Promoter Group | 0.7% | 18,18,683 |
| Santhi Sree Ramanavarapu | Shareholding of Promoter and Promoter Group | 0.3% | 8,46,878 |
| Suseela Devi Chigurupati | Shareholding of Promoter and Promoter Group | 0% | 65,000 |
| Nikhila Reddy Yedaguri | Shareholding of Promoter and Promoter Group | 0% | 29,500 |
| Harsha Chigurupati | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Kalidindi Abinav Varma | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Venkata Mahesh Krishna Narra | Shareholding of Promoter and Promoter Group | 0% | 0 |
Board of Directors
| Name | Designation | Year |
|---|---|---|
| C Krishna Prasad | CMD & Executive Director | 2025 |
| KANDIRAJU VENKATA SITARAMRAO | Non Independent Executive Director / Joint MD | 2025 |
| Uma Devi Chigurupati | ED (Non-Independent) | 2025 |
| Harsha Chigurupati | ED (Non-Independent) | 2025 |
| PRIYANKA CHIGURUPATI | NIED /Head /Promoter | 2025 |
| K B Sankara Rao | Non-Exec & Non-Independent Dir | 2025 |
| Arun Sawhney | Independent Non Exe. Director | 2025 |
| Saumen Chakraborty | Independent Non Exe. Director | 2025 |
| Sucharita Rao Palepu | Independent Non Exe. Director | 2025 |
| Kapil Mehan | Independent Non Exe. Director | 2025 |
| S Ravi | Independent Non Exe. Director | 2025 |
| Rajiv Kakodkar | Independent Non Exe. Director | 2025 |
| Chaitanya Tummala | Company Sec. & Compli. Officer | 2025 |
Segments — Product
| Segment | Revenue | Share |
|---|---|---|
| Pharmaceutical products including i | ₹0 Cr | — |
Segments — Geography
| Region | Revenue | Share |
|---|---|---|
| Outside India | ₹3,200 Cr | 92.1% |
| Within India | ₹274 Cr | 7.9% |
Capital Structure (₹ Cr)
| Year | Face Value | Authorised | Issued | Paid-up |
|---|---|---|---|---|
| 2026 | ₹1 | 51 | 25 | 25 |
Corporate Actions
| Type | Date | Value | Remark |
|---|---|---|---|
| forthcoming | 2026-07-30 | Dividend (1.75/- per share) | Final |
| dividend | 2026-07-30 | ₹1.75 (175%) | Final |
| forthcoming | 2026-07-21 | Board Meetings | — |
| dividend | 2025-07-31 | ₹1.5 (150%) | Final |
Related-Party Transactions (₹ Cr)
| Year | Subsidiaries | Associates | JV | KMP | Others | Total |
|---|---|---|---|---|---|---|
| 2026 | 5,875 | 0 | 0 | 411 | 59 | 6,346 |
| 2026 | 3,993 | 0 | 0 | 365 | 50 | 4,409 |
| 2026 | 56 | 0 | 0 | 46 | 8 | 110 |
Insider / Designated-Person Trades
11 recent disclosure(s)
Murali Mohana Raju GottumukkalaAcquisition · 20,000
Jaiashokan VelusamyAcquisition · 4,000
Chaitanya TummalaAcquisition · 17,660
Shaik KhaleelAcquisition · 10,000
Manikandan RamalingamAcquisition · 30,000
Maddargi Devendra KumarAcquisition · 40,000
Substantial Acquisitions (SAST)
2 disclosure(s)
Market10/07/2024 - 12/09/2024 · 60,60,786
Market19/01/2022 · 10,22,941
Company Information
Incorporated1991
ChairmanC Krishna Prasad
AuditorS R Batliboi & Associates LLP
Investor Email[email protected]; mail@granules
📍 15th Floor Granules Tower, Botanical Garden Road Kondapur, Hyderabad, Telangana, 500084
Technical AnalysisPremium
Technical analysis (Premium)
Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.
More stocks
Godawari Power & Ispat Ltd.Gujarat Pipavav Port Ltd.GPT Healthcare LimitedGPT Infraprojects Ltd.Gradiente Infotainment LimitedGrand Oak Canyons Distillery Ltd.Graphisads LimitedGraphite India Ltd.Grasim Industries Ltd.Grauer & Weil (India) Ltd.Graviss Hospitality Ltd.Gravita India LimitedAll “G” stocks →
Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search